- About Us
- Advertise
- Contact Us
- CureToday.com
- CancerNetwork.com
- OncLive.com
- OncNursingNews.com
- Do Not Sell My Information
- Privacy
- Terms & Conditions
© 2023 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Case-Based Roundtable Meetings Spotlight: July 1, 2022
Khan Reviews Later-Line Therapy Options for DLBCL With Subgroup Considerations
July 10, 2022
Clinical Articles
During a Targeted Oncology case-based roundtable event, Cyrus M. Khan, MD, discussed the data supporting the use of polatuzumab, bendamustine, and rituximab, tasfasitamab plus lenalidomide, and loncastuximab tesirine in patients with relapsed/refractory diffuse large B-cell lymphoma.
Clinical Commentary: Addressing Challenges in Unresectable HCC and Adding Lenvatinib to Therapy Sequencing
July 09, 2022
Clinical Articles
During a Targeted Oncology case-based roundtable event, Ghassan K. Abou-Alfa, MD, discussed therapeutic sequencing for patients with unresectable hepatocellular carcinoma and the use of lenvatinib versus sorafenib.
Roundtable Discussion: Barata Explores Second- and Third-Line Options for Recurrent RCC
July 08, 2022
Clinical Articles
During a Targeted Oncology case-based roundtable event, Pedro Barata, MD, MSc, discussed the case of a patient with clear cell renal cell carcinoma who progressed following frontline treatment with axitinib/pembrolizumab.
Rizzieri Considers Prognostic Models and Trial Data for Myelofibrosis
July 07, 2022
Clinical Articles
During a case-based roundtable event, David A. Rizzieri, MD, discussed the case of a 68-year-old patient with myelofibrosis.
Bishop Reviews Risk Assessment and Treatment for GVHD
July 06, 2022
Clinical Articles
Michael R. Bishop, MD, discussed a patient with graft-versus-host disease who first underwent a myeloablative conditioning regimen and peripheral blood stem-cell matched hematopoietic cell transplant as treatment.
Roundtable Discussion: Wagner-Johnson Highlights New and Emerging Approaches for DLBCL
July 06, 2022
Clinical Articles
Experts discuss the newest approaches for treating patients with diffuse large B-cell lymphoma.
Traina Discusses Components of the ASCENT Trial in Patients With TNBC
July 05, 2022
Clinical Articles
Tiffany A. Traina, MD, discussed the ASCENT Trial examining patients with triple negative breast cancer.
Roundtable Discussion: Stinchcombe Reviews Second-Line Therapy for ES-SCLC
July 05, 2022
Clinical Articles
During a Targeted Oncology case-based roundtable event Thomas E. Stinchcombe, MD, discussed the case of a 53-year-old patient with extensive-stage small cell lung cancer.
Burger Details the Data to Help Choose Treatment in Chronic Lymphocytic Leukemia
July 03, 2022
Clinical Articles
During a Targeted Oncology case-based roundtable event, Jan A. Burger, MD, PhD, discussed data supporting the use of ibrutinib, acalabrutinib, and zanubrutinib for first-line treatment of chronic lymphocytic leukemia.
McKay Discusses Important Updates in Treatment, Management of Clear Cell RCC
July 02, 2022
Clinical Articles
During a Targeted Oncology case-based roundtable event, Rana R. McKay, MD, discussed updates to key trials in advanced clear cell renal cell carcinoma.
Roundtable Discussion: Sabari Evaluates Immunotherapy, Targeted Therapy Options in ES-SCLC
July 01, 2022
Clinical Articles
During a case-based roundtable event, Joshua K. Sabari, MD, discussed the case of a 73-year-old woman with extensive-stage small cell lung cancer.